Lipids 1862 , 11781187 (2017)
Potential Risks and Side Effects The FDA states that compounded drugs containing AOD-9604 carry a significant risk for immunogenicity
22,23 In patients with a normal or low-normal serum vitamin B 12 level, complete blood count results demonstrating macrocytosis, or suspected clinical manifestations, a serum methylmalonic acid level is an appropriate next step 1,2,6,18 and is a more direct measure of vitamin B 12 's physiologic activity
suggested that tumor tissues showing high unsaturated binding capacity could be the source of the increased binding protein in the serum [46]
Hydroxocobalamin binds more tightly to serum proteins, creating a depot effect that allows for slower release and prolonged availability to tissues
This means healthcare providers can help patients with vitamin B12 deficiency get better by using proven methods (PMC11128391)